News - Respiratory and Pulmonary, Licensing


Popular Filters

1 to 25 of 45 results

AstraZeneca inks up to $232 million deal for Synairgen’s SNG001

AstraZeneca inks up to $232 million deal for Synairgen’s SNG001


Anglo-Swedish pharma major AstraZeneca has signed a global licence accord with Synairgen, an AIM-listed…

AstraZenecaChronic lower respiratory diseasesHealth Medical PharmaLicensingMajorMedicinePharmaceuticalPulmonologyRespiratory and PulmonarySNG001Synairgen

Aslan Pharma signs agreement with CSL to develop novel therapy for asthma


Singapore-based Aslan Pharmaceuticals has signed a global license agreement to develop an anti-interleukin…

ASLAN PharmaceuticalsBiotechnologyCSL LimitedCSL334LicensingRespiratory and Pulmonary

Bayer shells out $14.2 billion for Merck & Co OTC business; firms to collaborate on sGC modulators

Bayer shells out $14.2 billion for Merck & Co OTC business; firms to collaborate on sGC modulators


Confirming strong rumors over the past week or so, German pharma major Bayer confirmed it has agreed…

AdempasBayerLicensingMerck & CoMergers & AcquisitionsPharmaceuticalResearchRespiratory and Pulmonaryvericiguat

Cytos Biotech to wind down key operational activities


Switzerland-based Cytos Biotechnology has entered into agreements with major creditors resulting in a…

BiotechnologyCYT003Cytos BiotechnologyFinancialLicensingRespiratory and Pulmonary

ALK-Abello links with Eddingpharm to accelerate growth in China


Danish allergy specialist ALK-Abello and China-based specialty pharmaceutical company Eddingpharm have…

ALK AbelloAlutard SQAsia-PacificChinaEddingpharmLicensingPharmaceuticalRespiratory and Pulmonary

Prosonix and Mylan in deal for Flixotide and Flovent generics


Prosonix, a UK-based company which is developing a portfolio of inhaled “Respiratory Medicines by Design,”…

FloventGenericsGlaxoSmithKlineGlobalLicensingMylan LaboratoriesProsonixRespiratory and Pulmonary

Whooping cough vaccine agreement signed by ILiAD


US biotech company ILiAD Biotechnologies has signed scientific collaboration and worldwide license agreements…

BiotechnologyFranceILiAD BiotechnologiesLicensingResearchRespiratory and PulmonaryUSA

GNI Group out-licenses Etuary to AFT Pharma


Japan headquartered GNI Group, a clinical-stage bio-pharmaceutical company focusing on major diseases…

Asia-PacificLicensingPharmaceuticalRespiratory and Pulmonary

Kyorin expects $10 million sales after Flutiform launch in Japan for asthma

Kyorin expects $10 million sales after Flutiform launch in Japan for asthma


UK drug delivery specialist Skyepharma (LSE: SKP) has announced that Flutiform has been launched in Japan…

Asia-PacificFlutiformKyorin PharmaceuticalsLicensingPharmaceuticalRegulationRespiratory and PulmonarySkyepharma

Tris Pharma and FSC Labs enter Karbinal accord


Drug delivery specialist Tris Pharma and fellow USA-based privately-held company FSC Laboratories have…

FSC LaboratoriesKarbinalLicensingNorth AmericaPharmaceuticalRespiratory and PulmonaryTris Pharma

Meda expands collaboration with India's Cipla on Dymista


Swedish drugmaker Meda (OMX: MEDA A) is broadening its collaboration with Indian pharmaceutical company…

Asia-PacificCiplaDymistaLicensingMedaPharmaceuticalRespiratory and PulmonaryRest of the WorldSouth America

Grifols gains global rights to Aradigm's Pulmaquin


Spanish drugmaker Grifols (GRLS: MC) has signed an exclusive, worldwide license for USA-based Aradigm's…

Antibiotics and Infectious diseasesAradigmCiprofloxacinGrifolsLicensingMergers & AcquisitionsPharmaceuticalPulmaquinRespiratory and Pulmonary

Stallergenes and DBV Technologies partner on developing novel respiratory allergies treatments


French biotech firms DBV Technologies (Euronext: DBV), creator of Viaskin, a new standard in the treatment…

BiotechnologyDBV TechnologiesLicensingResearchRespiratory and PulmonaryStallergenes

Elan pays $1 billion for a 21% share of Theravance royalties on four respiratory programs


US biotech firm Theravance (Nasdaq: THRX) has entered into a royalty participation agreement wherein…

Anoro ElliptaBiotechnologyBreo ElliptaElanFinancialGlaxoSmithKlineLicensingPharmaceuticalRespiratory and PulmonaryTheravance

Roche pulls out of fibrosis alliance with Galapagos


Belgium-based Galapagos (Euronext Brussels: GLPG) revealed that Swiss drug major Roche (ROG: SIX) has…

GalapagosLicensingPharmaceuticalRespiratory and PulmonaryRoche

Sweden's Orexo in respiratory research accord with AstraZeneca


Swedish drug developer Orexo AB (STO: ORX) has entered into an agreement with Anglo-Swedish drug major…

AstraZenecaLicensingOrexo ABOX-CLIPharmaceuticalResearchRespiratory and Pulmonary

Infinity amends PI3K-delta, gamma accord with Millennium


US drug discovery firm Infinity Pharmaceuticals (Nasdaq: INFI) says it has amended its development and…

BiotechnologyFinancialInfinity PharmaceuticalsIPI-145LicensingMillennium PharmaceuticalsPharmaceuticalRespiratory and PulmonaryTakeda Pharmaceuticals

Cornerstone Thera gets US rights to Chiesi's Bethkis


USA-based specialty pharma firm Cornerstone Therapeutics Inc. (Nasdaq: CRTX) says it has entered into…

BethkisChiesi FarmaceuticiCornerstone TherapeuticsGenericsLicensingNorth AmericaPharmaceuticalRare diseasesRespiratory and Pulmonary

Almirall out-licenses aclidinium to Invida for Australia and New Zealand


Leading Spanish drugmaker Almirall (ALM: MC) has granted Singapore-based Invida, a member of the Italian…

aclidiniumAlmirallAsia-PacificInvidaLicensingMenariniPharmaceuticalRespiratory and Pulmonary

Unigene and Tarix report highly increased oral bioavailability of "Peptelligence-engineered" TXA127


USA-based Unigene Laboratories Laboratories (OTCBB: UGNE) and Tarix Pharmaceuticals yesterday announced…

Cardio-vascularLicensingPharmaceuticalResearchRespiratory and PulmonaryTarix PharmaceuticalsTXA127Unigene Labs

Salix and Alfa Wassermann expand rifaximin accord


USA-based Salix Pharmaceuticals (Nasdaq: SLXP) and Italy's Alfa Wassermann have entered into an exclusive…

Alfa WassermannGastro-intestinalsLicensingPharmaceuticalRespiratory and PulmonaryrifaximinSalix Pharmaceuticals

Lupin in deal to market Novartis' Onbrez in India, local newspaper reports


Indian drugmaker Lupin Pharmaceuticals (LOPN: BO) and Swiss major Novartis (NOVN: VX) have entered into…

Asia-PacificLicensingLupinMarkets & MarketingNovartisOnbrezPharmaceuticalRespiratory and Pulmonary

Boehringer Ingelheim acquires Funxional products


German family-controlled drug major Boehringer Ingelheim has entered an agreement to acquire the global…

Anti-Arthritics/RheumaticsBoehringer IngelheimFunxional TherapeuticsFX125LLicensingPharmaceuticalRespiratory and Pulmonarysomatotaxin

AstraZeneca gains rights to Rigel's asthma candidate R256


Anglo Swedish drug major AstraZeneca (LSE: AZN) and signed an exclusive global license accord with USA-based…

AstraZenecafostamatinibLicensingPharmaceuticalR256Respiratory and PulmonaryRigel Pharmaceuticals

1 to 25 of 45 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top